Department Of Physiology 3
101. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
102. Morphological and Structural Reaction of Avena sativa Seedlings to the Effects of Nano and Microparticles of Zinc
103. Developmental delay, seizures, and behavioral disorder caused by new SETD1B mutation: A case report
104. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
105. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
106. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
107. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
108. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
109. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
110. Sleep and Gonadotrophin Hormones
111. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
112. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021
113. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021
114. Understanding Platelet Activation in the Aeson Bioprosthetic Total Artificial Heart: Insights From Aspirin Treatment and Outcomes
115. Phytochemical Profiling of Ferula varia Extract and Its Antibiofilm Activity Against Streptococcus mutans
116. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
117. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
118. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
119. Bioorganic macromolecules crowned zirconia nanoparticles: protein-rich fish mucus inspired synthesis and their antibacterial efficacy assessment
120. Assessment of the Influence of Dust-Salt Aerosols of the Aral Sea on the Morphological Characteristics of the Tissue of the Epididymis of Rats in the Experiment
121. Morphometric Characteristics of Rat Testes Tissue After Exposure to Dust–Salt Aerosols of the Aral Sea
122. Morphometric Characteristics of Rat Testes Tissue After Exposure to Dust–Salt Aerosols of the Aral Sea
123. Body appreciation around the world: Measurement invariance of the Body Appreciation Scale-2 (BAS-2) across 65 nations, 40 languages, gender identities, and age
124. Exposure and connectedness to natural environments: An examination of the measurement invariance of the Nature Exposure Scale (NES) and Connectedness to Nature Scale (CNS) across 65 nations, 40 languages, gender identities, and age groups
125. Life satisfaction around the world: Measurement invariance of the Satisfaction With Life Scale (SWLS) across 65 nations, 40 languages, gender identities, and age groups
126. Self-Compassion Around the World: Measurement Invariance of the Short Form of the Self-Compassion Scale (SCS-SF) Across 65 Nations, 40 Languages, Gender Identities, and Age Groups
127. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
128. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
129. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
130. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
131. Comparative assessment of regulated methods and PCR in the diagnosis of trichophytosis in veterinary mycology
132. Apoptotic cell death in disease—Current understanding of the NCCD 2023
133. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
134. Chemical Composition and Antibacterial Activity of Subcritical CO2 Extract of Beta vulgaris L.
135. The Assessment of the Nutritional Status among the Young-Old and Old-Old Population with Alimentary-Dependent Diseases
136. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1 2 3 3